Highcroft Veterinary Referrals logo

Highcroft Veterinary Referrals extends soft tissue surgery service

30th November 2017

Highcroft Veterinary Referrals has extended its soft tissue surgery service with the appointment of two specialist surgeons, Dr Ivan Doran, a RCVS Specialist in Small Animal Soft Tissue Surgery, and Dr Ed Friend, a European Specialist in Small Animal Surgery. They join specialist surgeons Dr Dan Ogden and Dr Elinor Field.  Highcroft’s surgery services have been further strengthened with the appointment of Dr Delphine Holopherne-Doran, European Specialist in Veterinary Anaesthesia and Analgesia.

Bristol-based Highcroft Veterinary Group is one of the UK’s leading practices and joined CVS (UK) Ltd in 2015.  Its 24-hour hospital and referral centre sees patients from across the South West, West Country and South Wales.

Dr Doran graduated from Bristol University in 1997. He worked in Hertfordshire before completing a surgical residency under the tutelage of Professor Peter Holt at Bristol University. Ivan has worked in referral centres in the UK and France. He is an RCVS Diplomate in Small Animal Soft Tissue Surgery and a Recognised Specialist in Small Animal Soft Tissue Surgery.  Before joining Highcroft, he spent six years working as a senior staff surgeon at Bristol University.

Dr Friend graduated from the Royal Veterinary College (RVC) in 1996. He worked in a mixed practice in Buckinghamshire before undertaking training positions at the RVC, University of Liverpool and the University of Cambridge. He passed the specialist Diploma examinations of the European College of Veterinary Surgeons in 2003. He has previously been a senior surgeon and member of academic staff at the University of Bristol and has worked in private referral practice.

Dr Holopherne-Doran graduated from Maisons-Alfort (Paris) Vet School in 1998. After working as an equine vet, where she developed an interest in veterinary anaesthesia and analgesia, she returned to vet school in Nantes where she ran the Anaesthesia department for 11 years. During this time, she gained a Master’s degree and a PhD in cardiovascular pharmacology and completed a residency, gaining European board certification in anaesthesia and analgesia, which led her to visit and train in universities around the world.

Commenting on their appointment, Highcroft Hospital Director Mr Chris Mayers said: “Ivan and Ed bring a wealth of experience in urinary tract surgery and, in particular, in urinary incontinence to Highcroft. The most common presentations are juvenile animals with ectopic ureters or urethral sphincter mechanism incompetence (post-spay incontinence).  Ivan and Ed offer an innovative, minimally-invasive procedure using cystoscopically-guided laser ablation for patients with intramural ectopic ureters.  Interventional radiology techniques are also a major interest for the team providing new, minimally-invasive solutions for intrahepatic shunts. The two surgeons have firmly adopted Subcutaneous Ureteral Bypass Systems (SUBS) in treating cats with ureteral obstruction, typically caused by calculi.

“Delphine adds world-class expertise in anaesthesia and analgesia and is already making a huge contribution to our hospital. With a high degree of skill in managing cardiovascular physiology and pharmacology cases, Delphine boosts our ability to support highly challenging and complex patients. Her knowledge of the use of local and region blocks for treating highly challenging pain cases and the anaesthesia of complex cardiovascular patients provides outstanding care for patients and promotes the highest standard in analgesia.”

CVS Referrals Director Professor John Innes added: “Extending our specialist services to offer improved treatments which harness modern technology is important for CVS, so we are delighted to have Ivan and Ed join our established surgical team at Highcroft and the wider team of surgeons we have across our referral network. Combining this great surgical team with the excellent specialist anaesthesia offered by Delphine is the optimum solution to maximise efficacy and patient safety.”